217 related articles for article (PubMed ID: 27364943)
1. Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency.
Czaller I; Csuka D; Zotter Z; Veszeli N; Takács E; Imreh É; Varga L; Farkas H
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):175-9. PubMed ID: 27364943
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema.
Loffredo S; Bova M; Suffritti C; Borriello F; Zanichelli A; Petraroli A; Varricchi G; Triggiani M; Cicardi M; Marone G
Allergy; 2016 Jul; 71(7):989-96. PubMed ID: 26873113
[TBL] [Abstract][Full Text] [Related]
3. Flow-mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency.
Nebenführer Z; Szabó E; Kajdácsi E; Kőhalmi KV; Karádi I; Zsáry A; Farkas H; Cervenak L
Ann Allergy Asthma Immunol; 2019 Jan; 122(1):86-92. PubMed ID: 30312677
[TBL] [Abstract][Full Text] [Related]
4. The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency.
Csuka D; Munthe-Fog L; Skjoedt MO; Kocsis A; Zotter Z; Gál P; Varga L; Farkas H; Füst G; Garred P
Mol Immunol; 2013 Jul; 54(3-4):271-7. PubMed ID: 23318225
[TBL] [Abstract][Full Text] [Related]
5. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.
Farkas H; Csuka D; Gács J; Czaller I; Zotter Z; Füst G; Varga L; Gergely P
Clin Immunol; 2011 Oct; 141(1):58-66. PubMed ID: 21636327
[TBL] [Abstract][Full Text] [Related]
6. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
7. Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients.
Kajdácsi E; Jandrasics Z; Veszeli N; Makó V; Koncz A; Gulyás D; Köhalmi KV; Temesszentandrási G; Cervenak L; Gál P; Dobó J; de Maat S; Maas C; Farkas H; Varga L
Front Immunol; 2020; 11():794. PubMed ID: 32431708
[TBL] [Abstract][Full Text] [Related]
8. Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.
Kajdácsi E; Jani PK; Csuka D; Varga L; Prohászka Z; Farkas H; Cervenak L
J Clin Immunol; 2016 Feb; 36(2):160-70. PubMed ID: 26873707
[TBL] [Abstract][Full Text] [Related]
9. Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk.
Reshef A; Zanichelli A; Longhurst H; Relan A; Hack CE
Allergy; 2015 May; 70(5):506-13. PubMed ID: 25640891
[TBL] [Abstract][Full Text] [Related]
10. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.
Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M
Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency.
Andrási N; Veszeli N; Holdonner Á; Temesszentandrási G; Kőhalmi KV; Varga L; Farkas H
Int Immunopharmacol; 2020 Mar; 80():106216. PubMed ID: 31982824
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency.
Zotter Z; Nagy Z; Patócs A; Csuka D; Veszeli N; Kőhalmi KV; Farkas H
Orphanet J Rare Dis; 2017 Jan; 12(1):5. PubMed ID: 28069032
[TBL] [Abstract][Full Text] [Related]
13. Clinical Pattern and Acute and Long-term Management of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency.
Gómez-Traseira C; Pérez-Fernández E; López-Serrano MC; García-Ara MC; Pedrosa M; López-Trascasa M; Caballero T
J Investig Allergol Clin Immunol; 2015; 25(5):358-64. PubMed ID: 26727765
[TBL] [Abstract][Full Text] [Related]
14. Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency.
Cugno M; Zanichelli A; Bellatorre AG; Griffini S; Cicardi M
Allergy; 2009 Feb; 64(2):254-7. PubMed ID: 19076541
[TBL] [Abstract][Full Text] [Related]
15. Activation of the ficolin-lectin pathway during attacks of hereditary angioedema.
Csuka D; Munthe-Fog L; Hein E; Zotter Z; Prohászka Z; Farkas H; Varga L; Garred P
J Allergy Clin Immunol; 2014 Dec; 134(6):1388-1393.e1. PubMed ID: 25042985
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor expression on the surface of monocytes from a patient with hereditary angioedema.
Iwamoto K; Morioke S; Yanase Y; Uchida K; Hide M
J Dermatol; 2014 Oct; 41(10):929-32. PubMed ID: 25228395
[TBL] [Abstract][Full Text] [Related]
17. Management of dental-oral procedures in patients with hereditary angioedema due to C1 inhibitor deficiency.
Jurado-Palomo J; Muñoz-Caro JM; López-Serrano MC; Prior N; Cabañas R; Pedrosa M; Burgueño M; Caballero T
J Investig Allergol Clin Immunol; 2013; 23(1):1-6. PubMed ID: 23653967
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol.
Pappalardo E; Zingale LC; Cicardi M
Immunol Lett; 2003 May; 86(3):271-6. PubMed ID: 12706530
[TBL] [Abstract][Full Text] [Related]
19. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.
Henry Li H; Riedl M; Kashkin J
Clin Rev Allergy Immunol; 2019 Apr; 56(2):207-218. PubMed ID: 29909591
[TBL] [Abstract][Full Text] [Related]
20. The effect of long-term danazol treatment on haematological parameters in hereditary angioedema.
Kőhalmi KV; Veszeli N; Zotter Z; Csuka D; Benedek S; Imreh É; Varga L; Farkas H
Orphanet J Rare Dis; 2016 Feb; 11():18. PubMed ID: 26911866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]